<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Incidence of cerebral <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) is higher in patients with <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> (DM) than that in individuals without DM, and neuronal <z:mpath ids='MPATH_3'>apoptosis</z:mpath> determines the severity of <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>However, there is no effective therapy for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Granulocyte-colony stimulating factor (G-CSF), a potent hematopoietic factor, could inhibit <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of hematopoietic progenitor cells </plain></SENT>
<SENT sid="3" pm="."><plain>However, its effect on neuronal cells is still unclear </plain></SENT>
<SENT sid="4" pm="."><plain>In this study, we investigated the anti-<z:mpath ids='MPATH_3'>apoptosis</z:mpath> properties of G-CSF in neurons following focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in diabetic rats </plain></SENT>
<SENT sid="5" pm="."><plain>The diabetic condition was generated in rats by intravenous injection of <z:chebi fb="1" ids="9288">streptozotocin</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>After 6 weeks, diabetic rats underwent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) and received subcutaneous administration of G-CSF (50 microg/kg) daily for 7, 14 or 21 days </plain></SENT>
<SENT sid="7" pm="."><plain>We analyzed the changes in neurological severity scores, <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, number of apoptotic neurons, and the expression of G-CSF receptor, phosphorylated signal transducer and activator of transcription 3 (pSTAT3), cellular inhibitor of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> protein 2 (cIAP2), Bcl-2, and Bax in the brain tissue </plain></SENT>
<SENT sid="8" pm="."><plain>Bax is a pro-apoptotic member of the Bcl-2 protein family </plain></SENT>
<SENT sid="9" pm="."><plain>The DM rats treated with G-CSF not only showed the reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and <z:mp ids='MP_0006043'>decreased apoptosis</z:mp> cell number, but also presented improved neurological scores </plain></SENT>
<SENT sid="10" pm="."><plain>The G-CSF also increased the expression of pSTAT3, Bcl-2, and cIAP2 proteins as well as Bcl-2 mRNA, but inhibited Bax protein expression in the brain </plain></SENT>
<SENT sid="11" pm="."><plain>These results indicate that G-CSF partially increases neuronal survival by affecting <z:mpath ids='MPATH_3'>apoptosis</z:mpath> pathways </plain></SENT>
<SENT sid="12" pm="."><plain>G-CSF provides a potential treatment for <z:hpo ids='HP_0001297'>stroke</z:hpo> and other neurological dysfunction accompanied by neuronal <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
</text></document>